Young Chul Sung
31Patents
5h-index
64Co-inventors
72Inventor score
Filing activity: Nov 22, 1996 → Jun 13, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7867491B2 | Immunoglobulin fusion proteins | Chemistry; Metallurgy | 19 | Active |
| US8586038B2 | Chimeric immunoglobulin fusion proteins | Chemistry; Metallurgy | 7 | Active |
| US7910564B2 | Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant | Emerging Cross-Sectional Technologies | 7 | Active |
| US5843773A | Apoptosis regulating gene | Human Necessities | 5 | Expired |
| US8137674B2 | Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer | Chemistry; Metallurgy | 5 | Active |
| US10399291B2 | Smart contact lenses and smart glasses | Physics | 4 | Active |
| US8167628B2 | Polymer substrate for flexible display having enhanced flexibility | Emerging Cross-Sectional Technologies | 3 | Active |
| US9000139B2 | Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer | Emerging Cross-Sectional Technologies | 3 | Active |
| US8737921B2 | Communication system of detecting victim terminal and performing interference coordination in multi-cell environments | Electricity | 3 | Active |
| US6887484B2 | Vaccine composition containing a promoter peptide | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8103217B2 | Apparatus and method for radio communication | Electricity | 2 | Active |
| US8529899B2 | Human growth hormone immunoglobulin fusion proteins | Chemistry; Metallurgy | 2 | Active |
| US9399665B2 | Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US8586048B2 | G-CSF immunoglobulin fusion proteins | Chemistry; Metallurgy | 2 | Active |
| US12128076B2 | Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11708399B2 | Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases | Chemistry; Metallurgy | 1 | Active |
| US11357827B2 | Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein | Human Necessities | 1 | Active |
| US7253151B2 | Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8412104B2 | Method and apparatus of controlling inter cell interference based on cooperation of intra cell terminals | Electricity | 1 | Active |
| US10538569B2 | Fusion polypeptide containing GLP and immunoglobulin hybrid Fc and use thereof | Chemistry; Metallurgy | 1 | Active |
| US6818442B2 | AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys | Chemistry; Metallurgy | 0 | Expired |
| US11001620B2 | Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone | Physics | 0 | Active |
| US12410233B2 | Extracellular domain of alpha subunit of IgE Fc receptor, pharmaceutical composition comprising same and method for producing same | Chemistry; Metallurgy | 0 | Active |
| US9228202B2 | Intracellular viral vector delivery method employing iron ion/viral vector composite | Chemistry; Metallurgy | 0 | Active |
| US8586531B2 | Erythropoietin immunoglobulin fusion proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.